The push for smaller, smarter cancer trialsMarch 17, 2014Breast CancerGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung Cancer
Whole-genome sequencing not ready for prime timeMarch 13, 2014Practice ManagementGynecologic CancerBreast Cancer
Genomic analyses led to targeted treatment for metastatic breast cancer, though response rate disappointing March 11, 2014Breast Cancer
Prophylactic oophorectomy cuts all-cause mortality 77% in BRCA mutation carriersFebruary 27, 2014Breast CancerGynecologic Cancer
Guidelines: No ink on tumor is adequate surgical margin for early-stage breast cancerFebruary 12, 2014Breast Cancer
Removing opposite breast cuts 20-year mortality 48% in BRCA mutation carriers February 11, 2014Breast Cancer
No benefit seen for investigational antiangiogenic agent in metastatic breast cancerJanuary 23, 2014Breast Cancer
Will 100% coverage spur more use of breast cancer chemopreventives?January 22, 2014Breast CancerPractice Management
Extracorporeal shock wave therapy promising for lymphedemaJanuary 10, 2014Breast CancerPatient & Survivor Care
Survival no better after primary tumor removal in metastatic breast cancerDecember 27, 2013Breast Cancer
No overall benefit seen with bisphosphonate treatment in chemoresistant breast cancerDecember 26, 2013Breast Cancer
